Govt Job for Pharmacists in ECHS

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General.

There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Ex-Servicemen Contributory Health Scheme (ECHS) invites applications to engage the following vacancies on contractual basis in Ex-Servicemen Contributory Health Scheme Polyclinic, Devlali and Ex-Servicemen Contributory Health Scheme Polyclinic, Dhule for a period of one year.

Post : Pharmacist

No of Post :03 (Devlali-02, Dhule-01)
Age Limit : For Emp-53, For Contractual-55

Basic qualification :
(i) B.Pharmacy from recognized Institute OR
(ii) (10+2) with science stream from Recognized board
(iii) Approved Diploma in Pharmacy from Recongnized by the Pharmacy Council of India and Registered as Pharmacist under the Pharmacy Act 1948

Work Exp : Minimum 3 Year experience
Desirable Attributes : Any diploma / Course in specialist Pharmacy
Salary : Rs 28,100/-

Last date of receipt of application is 18 Mar 2021.

Interview will be conducted on 25 Mar 2021 at 1100 hrs at Station Headquarters Devlali.

Candidates will bring original certificates/degree, photocopy of testimonials and experience certificates as applicable at the time of interview.

Only those individuals will be called for interview who fulfill all the requisite criteria

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices